DAX24.137 +0,8%Est505.861 +0,9%MSCI World4.343 -0,1%Top 10 Crypto10,01 -3,9%Nas26.402 +1,2%Bitcoin67.808 -1,1%Euro1,1717 -0,2%Öl105,9 -1,7%Gold4.689 -0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 SAP 716460 Infineon 623100 Münchener Rückversicherungs-Gesellschaft 843002 Siemens Energy ENER6Y Deutsche Telekom 555750 Micron Technology 869020 Allianz 840400 Lufthansa 823212 Intel 855681 RENK RENK73 Plug Power A1JA81 AMD (Advanced Micro Devices) 863186 Bayer BAY001
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich fester -- Dow schließt etwas leichter - Tech-Indizes und S&P 500 mit neuen Rekorden -- Infineon, NVIDIA, Alibaba, Chip-Aktien, TUI, Telekom, Siemens, VW, Mercedes & Co. im Fokus
Top News
Krypto-Schock? Michael Saylor nennt Bitcoin-Verkäufe eine "Impfung" für den Markt Krypto-Schock? Michael Saylor nennt Bitcoin-Verkäufe eine "Impfung" für den Markt
Alibaba-Aktie dreht dennoch ins Plus: Massiver Gewinneinbruch enttäuscht Anleger Alibaba-Aktie dreht dennoch ins Plus: Massiver Gewinneinbruch enttäuscht Anleger
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & Musterdepots Tools & integriertes Trading Newsletter, Trading-Desk uvm.
Schon einen Account? Anmelden
Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Gilead Sciences Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
113,72 EUR -1,40 EUR -1,22 %
BMN
132,63 USD -0,49 USD -0,37 %
nachbörslich
BTT
finanzen.net zero
Gilead Sciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.141,46 Mrd. EUR

KGV18,10Div. Rendite2,57%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN885823

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS3755581036

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolGILD

Gilead Sciences Aktien News

DatumMeistgelesen
BenzingaHow Do Investors Really Feel About Gilead Sciences?
ZacksWhy Gilead Sciences (GILD) is a Top Value Stock for the Long-Term
ZacksBrokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet
BenzingaSynovus Financial, Gilead Sciences And More On CNBC's 'Final Trades'
ZacksGilead Sciences Rallies 27.2% in Six Months: Buy or Sell the Stock?
ZacksHas Gilead Sciences (GILD) Outpaced Other Medical Stocks This Year?
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
Benzinga$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
MotleyFoolGilead Sciences: A Mixed Bag of Opportunities and Risks
ZacksGilead Sciences (GILD) Beats Stock Market Upswing: What Investors Need to Know
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
ZacksGilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
ZacksGilead Sciences (GILD) Stock Moves -1.18%: What You Should Know
BenzingaGilead Bets On Kymera's CDK2 Molecular Glue Degrader For New Cancer Therapies
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
ZacksWhy Gilead Sciences (GILD) is a Top Momentum Stock for the Long-Term
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
ZacksInvestors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
ZacksIs It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?
MotleyFoolWhy Gilead Sciences Stock Tumbled on Tuesday
MotleyFoolWhy Gilead Scinces Stock Tumbled on Tuesday
ZacksGilead Reports Positive Data From Trodelvy, Keytruda Combo Study
ZacksGilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold?
ZacksHere is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
BenzingaWhat Analysts Are Saying About Gilead Sciences Stock
ZacksHere's Why Gilead Sciences (GILD) is a Strong Value Stock
ZacksGilead Sciences vs GSK: Which HIV Drugmaker is a Smarter Buy Now?
BenzingaIs the Market Bullish or Bearish on Gilead Sciences?
ZacksIs Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?
ZacksThe Zacks Analyst Blog Highlights Disney, Gilead Sciences, Eaton and Maui Land & Pineapple
ZacksTop Analyst Reports for Walt Disney, Gilead Sciences & Eaton
PR NewswireCIBC introduces additional U.S. Canadian Depositary Receipts ("CDRs")
PR NewswireCIBC introduces additional U.S. Canadian Depositary Receipts ("CDRs")
PR NewswireCognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications
PR NewswireHetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
PR NewswireHetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
PR NewswireHetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
PR NewswireGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
PR NewswireGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.